WA
Consensus Narrative from 4 Analysts
Launch Of OraQuick HCV Self-Test And Genomics Ventures Will Open Markets Amid Profitability Pressures
Key Takeaways The international launch of the OraQuick HCV Self-test and upcoming blood proteomics launch offer significant revenue and growth opportunities. Streamlining operations and internalizing production enhance efficiency, margins, and focus on high-growth and innovative sectors.
View narrativeUS$5.75
FV
32.9% undervalued intrinsic discount-16.95%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
1 day ago author updated this narrative